Aortic Stenosis in Elderly : Determinant of Progression

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

273 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-11-30

Study Completion Date

2017-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aortic stenosis (AS) is AS is caused by calcium deposits in the aortic valve. Calcification is progressive and eventually leads to reduced leaflet motion with obstruction of the left ventricular outflow. The only treatment is surgery. There are evidences that AS is a regulated process with similarities to atherosclerosis but determinants of AS progression are unknown. The study aims at evaluating these determinants and more specifically the role of lipids, inflammation and platelet aggregation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Aortic Stenosis: Determinants of Progression, Severity and Left Ventricular Remodeling

NCT03411317

Aortic Valve Stenosis

ACTIVE_NOT_RECRUITING

Coronary Artery Disease in Elderly People Referred for TAVI

NCT04930510

Aortic Stenosis Coronary Ang

UNKNOWN

Aortic Stenosis: Determinants and Prognostic Value of Preoperative Left Ventricular Remodeling After Valvular Replacement

NCT03411304

Aortic Valve Stenosis

ACTIVE_NOT_RECRUITING

Effective Management of Calcific Aortic Stenosis in the Elderly

NCT03343314

Calcific Aortic Stenosis

COMPLETED

Prognostic Impact of Myocardial Longitudinal Strain in Asymptomatic Aortic Stenosis: a Meta-Analysis

NCT02608567

Aortic Valve Stenosis Asymptomatic Conditions Left Ventricular Function

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aortic stenosis (AS) is the most common valvular disease and the second most common indication for cardiac surgery in Western countries. AS prevalence increases with age and with aging of the population, AS is a major public health problem. AS is due to calcium deposits within the aortic valve. Calcium deposit is progressive and eventually leads to reduced leaflet motion with obstruction of the left ventricular outflow. There is currently no effective medical therapy. Once the stenosis is severe and patients symptomatic, outcome is poor unless surgery (aortic valve replacement) is promptly performed. AS has long been considered as a passive and degenerative process. Recent data challenged this concept, showing that AS is an active and highly regulated process with some similarities to atherosclerosis. However, AS progression is highly variable from one individual to another and determinants of AS progression are poorly known. Their identification is crucial if we want to develop new medical strategies. The aims of the present study are to identify the determinants of AS progression and more specifically to evaluate the role of lipids, inflammation and platelet aggregation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Stenosis Elderly Gravida

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 70 years
* AS with mean transmitral gradient \> 10 mm Hg and aortic valve area \< 2 cm2
* No surgical indication

Exclusion Criteria

* Rheumatic or congenital AS
* Associated valvular disease grade ≥ 2/4
* Indication for surgery (severe AS (aortic valve area \< 1 cm2 or \< 0.6 cm2/m2 of body surface area and symptoms or congestive heart failure or left ventricular ejection fraction \< 50%)
* Renal insufficiency (creatinine clearance \< 30 ml /min)
* Left ventricular outflow tract obstruction

Minimum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No